MedTrace Logo

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

NCT00250237 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2009-08-07

No results posted yet for this study

Summary

In this study the investigators want to determine if treatment with haloperidol direct post-operatively after acute hip surgery in high risk patients protects against developing a post-operative delirium.

Conditions

  • Post-Operative Delirium
  • Hip Fracture

Interventions

DRUG

Haloperidol

Haloperidol 1mg twice daily during 72hours

DRUG

placebo

Placebo 1mg twice daily during 72hours

Sponsors & Collaborators

  • Bronovo Hospital

    lead OTHER

Principal Investigators

  • Boke Linso Sjirk Borger van der Burg, MD · Bronovo Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2008-11-30
Completion
2009-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00250237 on ClinicalTrials.gov